17-42780714-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_032387.5(WNK4):c.16G>A(p.Ala6Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0018 in 1,608,676 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A6D) has been classified as Uncertain significance.
Frequency
Consequence
NM_032387.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WNK4 | NM_032387.5 | c.16G>A | p.Ala6Thr | missense_variant | 1/19 | ENST00000246914.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WNK4 | ENST00000246914.10 | c.16G>A | p.Ala6Thr | missense_variant | 1/19 | 1 | NM_032387.5 | P1 | |
WNK4 | ENST00000591448.5 | c.16G>A | p.Ala6Thr | missense_variant, NMD_transcript_variant | 1/18 | 1 |
Frequencies
GnomAD3 genomes ? AF: 0.00929 AC: 1414AN: 152142Hom.: 21 Cov.: 32
GnomAD3 exomes AF: 0.00242 AC: 572AN: 236368Hom.: 8 AF XY: 0.00193 AC XY: 251AN XY: 130046
GnomAD4 exome AF: 0.00101 AC: 1473AN: 1456424Hom.: 27 Cov.: 31 AF XY: 0.000916 AC XY: 664AN XY: 724718
GnomAD4 genome ? AF: 0.00931 AC: 1417AN: 152252Hom.: 21 Cov.: 32 AF XY: 0.00916 AC XY: 682AN XY: 74436
ClinVar
Submissions by phenotype
WNK4-related disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 12, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 22, 2024 | - - |
Pseudohypoaldosteronism type 2B Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at